Cargando…
Synergistic immunotherapy targeting cancer-associated anemia: prospects of a combination strategy
Cancer-associated anemia promotes tumor progression, leads to poor quality of life in patients with cancer, and even obstructs the efficacy of immune checkpoint inhibitors therapy. However, the precise mechanism for cancer-associated anemia remains unknown and the feasible strategy to target cancer-...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199626/ https://www.ncbi.nlm.nih.gov/pubmed/37208766 http://dx.doi.org/10.1186/s12964-023-01145-w |